These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28827518)

  • 1. Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cells.
    Ranjan S; Goihl A; Kohli S; Gadi I; Pierau M; Shahzad K; Gupta D; Bock F; Wang H; Shaikh H; Kähne T; Reinhold D; Bank U; Zenclussen AC; Niemz J; Schnöder TM; Brunner-Weinzierl M; Fischer T; Kalinski T; Schraven B; Luft T; Huehn J; Naumann M; Heidel FH; Isermann B
    Nat Commun; 2017 Aug; 8(1):311. PubMed ID: 28827518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway.
    Zhang B; Yeo RWY; Lai RC; Sim EWK; Chin KC; Lim SK
    Cytotherapy; 2018 May; 20(5):687-696. PubMed ID: 29622483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Notch Signals Induce a Pathogenic Molecular Signature during Priming of Alloantigen-Specific Conventional CD4
    Chung J; Radojcic V; Perkey E; Parnell TJ; Niknafs Y; Jin X; Friedman A; Labrecque N; Blazar BR; Brennan TV; Siebel CW; Maillard I
    J Immunol; 2019 Jul; 203(2):557-568. PubMed ID: 31182480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
    Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
    Front Immunol; 2018; 9():3104. PubMed ID: 30733722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease.
    Le HT; Keslar K; Nguyen QT; Blazar BR; Hamilton BK; Min B
    Front Immunol; 2020; 11():181. PubMed ID: 32117306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity.
    Beres AJ; Haribhai D; Chadwick AC; Gonyo PJ; Williams CB; Drobyski WR
    J Immunol; 2012 Jul; 189(1):464-74. PubMed ID: 22649199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-transplant cyclophosphamide limits reactive donor T cells and delays the development of graft-versus-host disease in a humanized mouse model.
    Adhikary SR; Cuthbertson P; Nicholson L; Bird KM; Sligar C; Hu M; O'Connell PJ; Sluyter R; Alexander SI; Watson D
    Immunology; 2021 Oct; 164(2):332-347. PubMed ID: 34021907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.
    Bremm M; Huenecke S; Lehrnbecher T; Ponstingl E; Mueller R; Heinze A; Bug G; Quaiser A; Kapinsky M; Brehm C; Bader P; Schneider G; Klingebiel T; Koehl U
    J Immunol Methods; 2011 Oct; 373(1-2):36-44. PubMed ID: 21839739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease.
    Yang J; Ramadan A; Reichenbach DK; Loschi M; Zhang J; Griesenauer B; Liu H; Hippen KL; Blazar BR; Paczesny S
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30694220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mobilized Multipotent Hematopoietic Progenitors Promote Expansion and Survival of Allogeneic Tregs and Protect Against Graft Versus Host Disease.
    D'Aveni M; Notarantonio AB; Agbogan VA; Bertrand A; Fouquet G; Gastineau P; Garfa-Traoré M; De Carvalho M; Hermine O; Rubio MT; Zavala F
    Front Immunol; 2020; 11():607180. PubMed ID: 33643294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
    Wolf D; Barreras H; Bader CS; Copsel S; Lightbourn CO; Pfeiffer BJ; Altman NH; Podack ER; Komanduri KV; Levy RB
    Biol Blood Marrow Transplant; 2017 May; 23(5):757-766. PubMed ID: 28219835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity.
    Vaeth M; Bäuerlein CA; Pusch T; Findeis J; Chopra M; Mottok A; Rosenwald A; Beilhack A; Berberich-Siebelt F
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1125-30. PubMed ID: 25583478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rγ(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease.
    Covassin L; Laning J; Abdi R; Langevin DL; Phillips NE; Shultz LD; Brehm MA
    Clin Exp Immunol; 2011 Nov; 166(2):269-80. PubMed ID: 21985373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Free Radical Scavenger NecroX-7 Attenuates Acute Graft-versus-Host Disease via Reciprocal Regulation of Th1/Regulatory T Cells and Inhibition of HMGB1 Release.
    Im KI; Kim N; Lim JY; Nam YS; Lee ES; Kim EJ; Kim HJ; Kim SH; Cho SG
    J Immunol; 2015 Jun; 194(11):5223-32. PubMed ID: 25911749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-versus-host disease reduces regulatory T-cell migration into the tumour tissue.
    Dürr C; Follo M; Idzko M; Reichardt W; Zeiser R
    Immunology; 2012 Sep; 137(1):80-8. PubMed ID: 22681312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease.
    Nishikii H; Kim BS; Yokoyama Y; Chen Y; Baker J; Pierini A; Alvarez M; Mavers M; Maas-Bauer K; Pan Y; Chiba S; Negrin RS
    Blood; 2016 Dec; 128(24):2846-2858. PubMed ID: 27760760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance induction between two different strains of parental mice prevents graft-versus-host disease in haploidentical hematopoietic stem cell transplantation to F1 mice.
    Guo Y; Zhang L; Wan S; Sun X; Wu Y; Yu XZ; Xia CQ
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1035-41. PubMed ID: 24661874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease.
    Pillai AB; George TI; Dutt S; Strober S
    Blood; 2009 Apr; 113(18):4458-67. PubMed ID: 19221040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells.
    Leclerc M; Naserian S; Pilon C; Thiolat A; Martin GH; Pouchy C; Dominique C; Belkacemi Y; Charlotte F; Maury S; Salomon BL; Cohen JL
    Blood; 2016 Sep; 128(12):1651-9. PubMed ID: 27506541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of AMPK minimizes graft-versus-host disease through an early impact on effector donor T cells.
    Monlish DA; Beezhold KJ; Chiaranunt P; Paz K; Moore NJ; Dobbs AK; Brown RA; Ozolek JA; Blazar BR; Byersdorfer CA
    JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34291733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.